Sypl1-flox Mouse
Common Name
Sypl1-flox
제품 ID
S-CKO-04403
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-19027-Sypl1-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Sypl1-flox Mouse (카탈로그 번호 S-CKO-04403)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Sypl1-flox
품종 계통계통 ID
CKOCMP-19027-Sypl1-B6J-VA
유전자명
제품 ID
S-CKO-04403
유전자 별칭
PanI, Pphn, Sypl, D12Ertd446e
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 12
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000076698
NCBI 전사체 ID
NM_013635
타겟 영역
Exon 3
유효 영역 크기
~0.6 kb
유전자 연구 개요
SYPL1, also known as synaptophysin-like 1, is a neuroendocrine-related tetratransmembrane transport vesicle protein [2,7]. It is involved in vesicle-related pathways, which are crucial for various biological processes. In the context of sperm development, it defines a vesicular pathway essential for sperm cytoplasmic droplet formation, which is important for male fertility [1]. In cancer, it has been associated with tumor-related processes, indicating its overall biological importance in both normal and disease-related biological systems. Genetic models, such as gene knockout mouse models, can be valuable for studying its functions.
Genetic ablation of SYPL1 in mice showed that it dictates the formation and accumulation of saccular elements in the forming cytoplasmic droplet of late spermatids and epididymal sperm. SYPL1 vesicles, derived from the Golgi, are critical for segregating key metabolic enzymes within the cytoplasmic droplet, which are required for sperm development and male fertility [1].
In pancreatic ductal adenocarcinoma (PDAC), gain-of-function and loss-of-function experiments demonstrated that SYPL1 promotes cell proliferation and protects cells from apoptosis. Knockdown of SYPL1 led to sustained extracellular-regulated protein kinase (ERK) activation and cell death, which was related to upregulated reactive oxygen species (ROS) [2].
In colorectal cancer, SYPL1 was upregulated at both mRNA and protein levels. Serum SYPL1 (sSYPL1) was significantly higher in CRC patients compared to controls and adenoma patients, and could distinguish CRC patients from them with high sensitivity and specificity. Fecal SYPL1 (fSYPL1) also showed high performance in distinguishing CRC patients from controls, and its level was positively correlated with tumor-related features. The levels of sSYPL1 and fSYPL1 declined significantly after radical surgery [3,4].
In hepatocellular carcinoma (HCC), SYPL1 overexpression was closely correlated with several malignant clinicopathologic features, and was identified as an independent prognostic factor for overall survival and disease-free survival. It may be associated with epithelial-mesenchymal transition (EMT) of HCC cells [5].
In oral squamous cell carcinoma (OSCC), YY1 promotes OSCC cell progression via up-regulating Kcnq1ot1 to sponge miR-506-3p and elevate SYPL1 [6].
In glioblastomas, SYPL1 was found to be upregulated in PRNPhigh/PRNP + cells, and vesicular dynamics signatures were strongly correlated with PRNP/PrPC levels where SYPL1 is involved [8].
In a study on JNK1/JNK3 interactome, SYPL1 was identified as a typical JBD-dependent interactor shared by JNK1α1 and JNK3α1 [9].
In conclusion, SYPL1 plays essential roles in multiple biological processes. In male fertility, it is crucial for sperm cytoplasmic droplet formation. In various cancers including PDAC, CRC, HCC, and OSCC, it is involved in processes such as cell proliferation, apoptosis, and metastasis, influencing cancer prognosis. The study of SYPL1 using gene knockout mouse models and other functional experiments has provided important insights into these functions, which may help in understanding the mechanisms of related diseases and developing potential therapeutic strategies.
References:
1. Liu, Jiali, Hermo, Louis, Ding, Deqiang, Hess, Rex A, Chen, Chen. 2023. SYPL1 defines a vesicular pathway essential for sperm cytoplasmic droplet formation and male fertility. In Nature communications, 14, 5113. doi:10.1038/s41467-023-40862-1. https://pubmed.ncbi.nlm.nih.gov/37607933/
2. Song, Yunda, Sun, Xuesong, Duan, Fangting, Wang, Jun, Li, Shengping. 2020. SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation. In Frontiers in oncology, 10, 1482. doi:10.3389/fonc.2020.01482. https://pubmed.ncbi.nlm.nih.gov/33042794/
3. Liu, Lei, He, Qiao, Li, Yan, Song, Xiaoyu, Guo, Yuanbiao. 2020. Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer. In Clinica chimica acta; international journal of clinical chemistry, 509, 36-42. doi:10.1016/j.cca.2020.05.048. https://pubmed.ncbi.nlm.nih.gov/32502495/
4. Shu, Tao, Wu, Kaiwen, Guo, Yuanbiao, Liu, Lei, Sun, Xiaobin. 2022. Evaluation of fecal SYPL1 as a diagnostic biomarker in colorectal cancer. In Clinical biochemistry, 103, 8-15. doi:10.1016/j.clinbiochem.2022.02.009. https://pubmed.ncbi.nlm.nih.gov/35218739/
5. Chen, Dong-Han, Wu, Qiu-Wan, Li, Xiu-Dong, Wang, Shuang-Jia, Zhang, Zhi-Ming. 2017. SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition. In Oncology reports, 38, 1533-1542. doi:10.3892/or.2017.5843. https://pubmed.ncbi.nlm.nih.gov/28731154/
6. Ding, Yi, Duan, Heng, Lin, Jian, Zhang, Xuanxuan. 2022. YY1 accelerates oral squamous cell carcinoma progression through long non-coding RNA Kcnq1ot1/microRNA-506-3p/SYPL1 axis. In Journal of ovarian research, 15, 77. doi:10.1186/s13048-022-01000-5. https://pubmed.ncbi.nlm.nih.gov/35778739/
7. Liu, Lei, Yao, Xue, Wang, Yanrong, Liu, Jinbo, Guo, Yuanbiao. 2022. Physins in digestive system neoplasms. In Advances in clinical chemistry, 111, 157-176. doi:10.1016/bs.acc.2022.08.002. https://pubmed.ncbi.nlm.nih.gov/36427909/
8. Boccacino, Jacqueline Marcia, Dos Santos Peixoto, Rafael, Fernandes, Camila Felix de Lima, da Rocha, Edroaldo Lummertz, Lopes, Marilene Hohmuth. 2024. Integrated transcriptomics uncovers an enhanced association between the prion protein gene expression and vesicle dynamics signatures in glioblastomas. In BMC cancer, 24, 199. doi:10.1186/s12885-024-11914-6. https://pubmed.ncbi.nlm.nih.gov/38347462/
9. Chen, Wei-Kai, Yeap, Yvonne Y C, Bogoyevitch, Marie A. 2014. The JNK1/JNK3 interactome--contributions by the JNK3 unique N-terminus and JNK common docking site residues. In Biochemical and biophysical research communications, 453, 576-81. doi:10.1016/j.bbrc.2014.09.122. https://pubmed.ncbi.nlm.nih.gov/25301550/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
